top of page

News & Events

Navigating Liability in The Cruise Ship Industry: What Types of Insurance do Vendors, Suppliers, and Logistics Companies Need?

Working within the cruise ship industry offers lucrative opportunities for vendors, suppliers and logistic companies, but it also comes with inherent maritime risks. Having the right maritime insurance coverage based on the products and services you provide is critical to not only protecting your business but also required by cruise lines to secure a third-party contract. Rahn & Associates outlines the various coverages in our latest blog.

​

​

​

If you are attending Seatrade Cruise Global in Miami, let's meet up! Click here to book a free consultation so we may discuss your needs and develop a customized, cost-effective policy that will protect you while you are under a cruise line/ship’s contract.

​

S2S and R&A Social Graphics-2.png

R&A PSYINS Examines the Necessary Insurance Coverages for Drug Developers Bringing Psychedelic Treatments to Market

Navigating the insurance landscape is a critical aspect of bringing psychedelic medicinal products to market. From the research and development phase to clinical trials, to manufacturing and distribution, having the right insurance coverages is essential for mitigating risks, ensuring compliance, and safeguarding the company's assets and reputation.

​

R&A PSYINS, our psychedelic insurance division, examines the necessary insurance coverages for bringing psychedelic treatments to market. Click on the link below to read the article.

​

If you have questions regarding psychedelic business insurance or would like a detailed risk assessment and analysis, please contact Eric Rahn for a consultation at (954) 790-6604 or email eric@rahn-associates.com

shutterstock_1105141013.jpg

R&A PSYINS Issues “Psychedelic Medicine Year-End Analysis and 2024 Outlook” Report

R&A PSYINS, our psychedelic insurance division,

released its Psychedelic Medicine Year-End Analysis and 2024 Outlook: “Navigating the Opportunities, Challenges and Unique Risks of Providing Breakthrough Treatments.” 

​

Produced in partnership with Neuly and Psychedelic Invest, the report discusses the catalysts that could propel the industry forward, emerging opportunities and challenges, and the specific Business Liability insurances that will be important for psychedelic businesses and practitioners to secure in 2024. 

​

If you have questions regarding psychedelic business insurance or would like a detailed risk assessment and analysis, please contact Eric Rahn for a consultation at (954) 790-6604 or email eric@rahn-associates.com

Social R&A PSYINS Psychedelic Medicine Year-End Analysis & 2024 Outlook.png

Rahn & Associates Sponsors reMind Psychedelic Business Conference

R&A PSYINS, our psychedelic insurance division, is pleased to sponsor reMind 2023 Psychedelics Business Forum on November 28-29, 2023 in Las Vegas.

​

As more therapy-focused psychedelic drugs are legalized for medicinal use and more companies and professionals get licensed, accessing critical insurance coverages becomes paramount. We look forward to educating attendees about our Professional Liability Insurances, General Liability, Cyber Defense, and other custom policies.

​

To schedule a one-on-one meeting at reMind with Eric Rahn and David Rahn, please click here or email eric@rahn-associates.com.

R&SPSYINS_reMind.png

NCIA Risk Management & Insurance Committee Releases "A Novel Cannabinoid Conundrum - Loopholes, Liability, and Legislation"

National Cannabis Industry Association recently released "A Novel Cannabinoid Conundrum - Loopholes, Liability, and Legislation." This comprehensive manual is brought to you by NCIA's Risk Management & Insurance Committee, co-chaired by Eric Rahn, whose mission is to promote the interests of the cannabis industry's risk management and insurance sectors, and develop strategies for their responsible advancement.

 

We understand the challenges and complexities faced by cannabis operators in today's ever-changing landscape. That's why our Risk Management & Insurance Committee has painstakingly compiled this updated manual to help you navigate the intricacies of the cannabis insurance sector with a special focus on novel cannabinoids and their impact on product liability policies.

Risk Management and Insurance Manual_ A Novel Cannabinoid Conundrum - Loopholes, Liability

Eric & David Rahn Featured on Psychedelic Invest Podcast About Psychedelic Medicine Insurance

In the latest episode of the Psychedelic Invest Podcast, host Bruce Eckfeldt interviews Eric Rahn and David Rahn about insuring the emerging psychedelic industry and the coverages they provide ketamine clinics, therapists and other licensed medical professionals. Click here to listen to the podcast: https://www.podbean.com/ew/pb-fvn9t-13f1aca

​

Psychedelic Invest Podcast.png

R&A PSYINS and Psychedelic Invest Host “Trials and Triumphs of Operating a Ketamine Clinic” Webinar

R&A PSYINS, a division of Rahn & Associates that focuses exclusively on the psychedelic medicinal industry, in partnership with Nucleus Holding, Inc. “(Nucleus”), a venture studio which owns and operates a portfolio of companies that connects stakeholders within the psychedelics industry, released a webinar on the Nucleus Psychedelic Invest network entitled “Trials and Triumphs of Operating a Ketamine Clinic.” Listen to experienced operators of ketamine clinics in the U.S. share their journey on starting and administering ketamine-assisted therapy.

Ways Your Psychedelic Business Can Avoid Insurance Landmines

Psychedelic medicine is an emerging industry that is still developing with highly complex regulations and a shifting legal landscape. The risks are high, and making mistakes with your insurance could cost you more than you know.

 

Psychedelic Invest and R&A PSYINS teamed up to write an article about the major insurance landmines to avoid when it comes to keeping your company safe.

 

Click here to read the article. 

​

Psychedelic Invest Features R&A PSYINS article: "Protecting Your Ketamine Clinic: Key Questions Answered about Business Liability Insurance."

Rahn & Associates' psychedelic industry insurance division, R&A PSYINS, published an article on how Ketamine Clinics can access the insurance they need to protect their business. 

​

The article was featured by Psychedelic Invest and provides answers below to the most pressing questions Ketamine clinics have about procuring the proper insurance. 

 

Click here to read the article. 

​

R&A PSYINS_Insurance for Ketamine Clinics.png

R&A PSYINS Announces Strategic Partnership with Nucleus Holding, Inc. to Provide the Psychedelic Medicinal Industry Access to Insurance Coverage

Rahn & Associates' psychedelic industry insurance division, R&A PSYINS, announced a strategic partnership with Nucleus Holding, Inc. “(Nucleus”), a venture studio which owns and operates a portfolio of companies that connects stakeholders within the psychedelics industry.

 

This new partnership will benefit all stakeholders in Nucleus’ robust ecosystem by providing them access to critical insurance coverages that will ensure they are fully protected and in compliance with state and federal HIPPA regulations.

​

Click here to read the press release.

Rahn & Associates to Participate in Wonderland: Miami on November 3-5, 2022

Rahn & Associates' is heading to Microdose’s Wonderland: Miami, the largest psychedelic medicine business event ever held, on November 3-5, 2022.

​

We look forward to educating attendees about our psychedelic medicinal insurance solutions designed specifically to help businesses offering wellness and nutraceutical products using psychoactive ingredients finally access the coverages they need to protect their business, attract, and retain qualified officers and directors, and bring new and innovative treatments to market.

​

To schedule a one-on-one meeting at Wonderland with Eric Rahn, Managing Director, please click here or email eric@rahn-associates.com.

R&A Wonderland Miami Graphic.png

Rahn & Associates Announces David Rahn as VP of Account Services

Rahn & Associates, an international bespoke insurance broker that offers risk management solutions specifically for highly regulated industries, announced today that David Rahn has rejoined the company as Vice President of Account Services.

 

David is a specialized insurance and risk management professional who assists companies operating in highly regulated industries minimize their risks and access critical coverages to safeguard their businesses. As a Bespoke Insurance Broker with strong analytical skills, he performs detailed risk assessments for both start-up and established, public and private companies, and develops customized strategies and solutions to ensure their businesses and C-suite executives are fully protected.

R&A Welcomes David Rahn to the Team.png

Law360 Interviews Eric Rahn for an article entitled, "Insuring Psychedelic Therapy Key to Promising Industry"

As research continues to support the use of Psychedelics and plant base medicine to potentially treat a range of mental health and behavioral disorders, the success of this growing movement partly depends on the ability of therapy providers to secure insurance coverage. Law360 recently interviewed Eric Rahn for an article entitled "Insuring Psychedelic Therapy Key to Promising Industry." Click here or on the button below to read the article.

 

Rahn & Associates is at the forefront of this new psychedelic movement providing licensed trainers, guides and psychedelic retreats both in the U.S. and abroad with Professional Liability Insurances, General Liability, Cyber Defense and other custom policies. Click here to schedule a consultation with Eric Rahn.

Rahn & Associates_Insuring Psychedelic Therapy_Law360.png.png

MJBiz Daily Features Eric Rahn's article, "The battle for directors and officers liability coverage in the cannabis industry."

Eric Rahn of S2S Insurance Specialists, published an exclusive article for MJBiz Daily entitled: "The battle for directors and officers liability coverage in the cannabis industry." As operators try to navigate the regulatory minefield while dealing with market volatility and mounting pressure to turn a profit, we’re witnessing a surge of legal action against companies’ boards of directors. Read the article for valuable advice on how to make it a smoother process to secure the D&O coverage.

MJBIZ copy.png

S2S Insurance Specialists is sponsoring, exhibiting and presenting at the Cannabis LAB Conference on June 3-4 in Miami

S2S Insurance Specialists is proud to sponsor the Cannabis LAB 6th Annual Conference and Expo on June 3-4 in Miami, FL. Visit us at Booth 217 and join us for our panel "Why is the cannabis industry so complicated? Break down the main barriers to achieve success!" on Friday, June 4th, 4-5pm. Get 20% off your conference ticket by using our code "S2S22" www.clabconference.com

To book a meeting with Eric Rahn, click on the link below:

See you there!

S2S Insurance Specialists CLab Sponsor Graphic.jpg

Rahn & Associates Launches Risk Management Solutions Specifically for Psychedelic Medicinal Businesses

Psychedelic medicinal businesses are finding it difficult to find the right coverages or any coverage at all in this current hardened insurance market, leaving them exposed to a wide spectrum of risks, many of which are unforeseen at this early stage of development. Complicating matters, each state has their own set of laws, which are rapidly evolving. In response, Rahn & Associates developed a risk management program that offers premium access to specialty lines of insurance products, including Directors & Officers Liability (including Excess Liability,) Product Liability, Professional Liability, IP Defense/Enforcement, Cyber Defense/Data Breach and other insurance coverages.

Rahn & Associates Psychedelic Medicine Insurance

We were recently featured in Business Insurance for the launch of our new Psychedelic Medicinal Insurance program. To learn more about our offerings, click here:

Business Insurance Magazine Rahn & Associates.jpg

NCIA Risk Management Committee Releases Risk Management and Insurance Manual ~ An Introduction to Cannabis Insurance

The National Cannabis Industry Association’s Risk Management & Insurance Committee, co-chaired by Managing Director Eric Rahn, has released the first in a series of insurance manuals designed to provide a broad introduction to risk management and insurance coverage for cannabis industry operators.


Cannabis and hemp businesses must be proactive in developing a risk management program that conforms to local and state compliance and security requirements. This Risk Management and Insurance Manual is a beginner's guide that explores the various insurable risks attributed to the cannabis supply chain and helps cannabis industry operators understand how they can best manage their risks.

NCIA Insurance Manual

Rahn & Associates Featured During Seatrade Cruise Tech & Innovation Show

Managing Director Eric Rahn was a featured guest during Seatrade Cruise Innovation Buzz Session as part of the Virtual Tech & Innovation Show. Click below to learn about all the new developments, trends, opportunities and challenges in the Cruise and Maritime Industry, particularly as it relates to Commercial Marine Insurance and Concessionnaire's Insurance. 

Seatrade Cruise
bottom of page